Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDAntares Pharma, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 05/10/2022 | Q1 2022 | -$0.00 | -$0.01 | -0.01 | N/A | $41.56 M |
| 03/03/2022 | Q4 2021 | $0.01 | $0.19 | 0.18 | N/A | $48.73 M |
| 11/04/2021 | Q3 2021 | $0.03 | $0.03 | 0.01 | N/A | $48.19 M |
| 08/05/2021 | Q2 2021 | $0.02 | $0.04 | 0.02 | N/A | $44.98 M |
| 05/06/2021 | Q1 2021 | $0.01 | $0.02 | 0.01 | N/A | $42.08 M |
| 03/02/2021 | Q4 2020 | $0.04 | $0.31 | 0.28 | N/A | $44.13 M |
| 11/05/2020 | Q3 2020 | $0.02 | $0.03 | 0.01 | N/A | $40.00 M |
| 08/06/2020 | Q2 2020 | $0.00 | $0.01 | 0.01 | N/A | $32.38 M |
| 05/05/2020 | Q1 2020 | -$0.00 | -$0.01 | -0.01 | N/A | $33.08 M |
| 03/03/2020 | Q4 2019 | $0.00 | $0.03 | 0.03 | N/A | $37.84 M |
| 11/05/2019 | Q3 2019 | $0.00 | $0.01 | 0 | N/A | $34.31 M |
| 08/06/2019 | Q2 2019 | -$0.01 | -$0.01 | -0.01 | N/A | $28.43 M |
| 05/02/2019 | Q1 2019 | -$0.02 | -$0.03 | -0.01 | N/A | $23.29 M |
| 03/12/2019 | Q4 2018 | N/A | $0.04 | N/A | N/A | $18.82 M |
| 11/06/2018 | Q3 2018 | -$0.01 | -$0.01 | -0 | N/A | $17.87 M |
| 08/07/2018 | Q2 2018 | -$0.02 | -$0.03 | -0.01 | N/A | $14.16 M |
| 05/08/2018 | Q1 2018 | -$0.03 | -$0.04 | -0.01 | N/A | $12.70 M |
| 03/13/2018 | Q4 2017 | -$0.02 | -$0.02 | -0.01 | N/A | $14.04 M |
| 11/07/2017 | Q3 2017 | -$0.03 | -$0.03 | -0.01 | N/A | $15.05 M |
| 08/08/2017 | Q2 2017 | -$0.02 | -$0.02 | -0 | N/A | $13.42 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Antares Pharma, Inc. Earnings: FAQ's
Antares Pharma, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 10th, 2022 based offlast year's report dates.
The conference call for Antares Pharma, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Antares Pharma, Inc.'s latest earnings report can be read online.
Antares Pharma, Inc. (:ATRS) has a recorded annual revenue of $183.98 M.
Antares Pharma, Inc. (:ATRS) has a recorded net income of $46.29 M.Antares Pharma, Inc. has generated $0.27 earnings per share over the last four quarters.
Antares Pharma, Inc. (:ATRS) has a price-to-earnings ratio of 20.55 and price/earnings-to-growth ratio is 0.21.